KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Other financing activities (2019 - 2020)

Historic Other financing activities for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q1 2020 value amounting to $41.1 million.

  • Xenon Pharmaceuticals' Other financing activities changed N/A to $41.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $41.1 million, marking a year-over-year change of. This contributed to the annual value of $40.6 million for FY2019, which is N/A changed from last year.
  • As of Q1 2020, Xenon Pharmaceuticals' Other financing activities stood at $41.1 million.
  • Xenon Pharmaceuticals' 5-year Other financing activities high stood at $41.1 million for Q1 2020, and its period low was $40.6 million during Q4 2019.